Worksport Reports Record FY 2025 with 90% Revenue Growth, Issues Aggressive 2026 Guidance Amid Unresolved Execution Risks

What happened

Worksport announced FY 2025 results featuring a 90% year-over-year revenue increase and margin expansion, primarily driven by its core tonneau cover business rather than new clean-energy products. The company set 2026 revenue guidance of $35 million to $42 million, a sharp rise from 2025 levels, and targets initial cash flow positivity. However, the DeepValue report highlights that past growth has stemmed from cover launches and marketing efforts, with SOLIS and COR products yet to demonstrate repeatable sell-through. Critical near-term catalysts, such as UL/CSA certifications for COR expected in Q1 2026, remain unconfirmed and are essential for big-box retail access. Despite the optimistic outlook, Worksport continues to face going-concern doubts, persistent net losses, and reliance on external financing, casting uncertainty on its ability to meet guidance without further dilution.

Implication

The strong FY 2025 performance indicates operational scaling in the core business, but the leap to $35M–$42M in 2026 revenue depends heavily on successful rollout of SOLIS and COR, which lack verifiable retail traction. Cash flow positivity is a positive target, yet past cash burn and equity raises suggest ongoing financing needs could lead to dilution if execution falters. The guidance does not address the immediate risks: UL/CSA certifications for COR are still expected, not confirmed, and without them, big-box retail pathways remain blocked. Inventory has risen to $6.8M, increasing reserve risk if new product sales underperform, potentially worsening cash flow. Ultimately, investors should await proof of certifications and named retailer listings before considering the guidance credible, to avoid capital impairment from potential equity offerings at distressed terms.

Thesis delta

The news does not materially shift the 'WAIT' thesis, as it emphasizes growth but fails to resolve the critical de-risking events outlined in the DeepValue report. While the guidance raises the stakes for product commercialization, the absence of certification updates and verifiable retail partnerships means the primary risk of dilution from ongoing losses remains unchanged. Therefore, the call to wait for concrete proofs before investing stands, with the timeline for reassessment still tied to Q1 2026 certification outcomes and mid-2026 listing evidence.